Procurement Summary
Country : Belgium
Summary : Supply of Omalizumab 2024-2028
Deadline : 01 Oct 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 106326346
Document Ref. No. : 513189-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The purpose of this contract is the supply of Omalizumab, a biosynthetic humanized anti-IgE monoclonal antibody for the treatment of asthma in patients with IgE dependence or chronic urticaria.
SUPPLY OF OMALIZUMAB 2024-2028
Doc Title : SUPPLY OF OMALIZUMAB 2024-2028
Contract
Document Type: Contract Notice
Reference Number: PPP0L1-35551/4637/2024-0322
Contract Type: supplies
Authority Type: grp-p-aut
Doc Title: FOURNITURE D'OMALIZUMAB 2024-2028
Dispatch Date: 2024-08-23
Publish Date: 2024-08-27
Submission Date: 2024-10-01
Documents
Tender Notice